Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
40.75 USD | +0.74% | +1.09% | +48.18% |
Apr. 19 | Gilead Sciences Likely to Record IPR&D Hit on Q1 Non-GAAP Earnings, Oppenheimer Says | MT |
Mar. 28 | Truist Securities Initiates Coverage on Merus With Buy Rating, $69 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+48.18% | 2.4B | |
-0.49% | 105B | |
+3.31% | 97.5B | |
+2.59% | 22.19B | |
-16.16% | 21.33B | |
-7.38% | 18.68B | |
-41.41% | 16.6B | |
-22.87% | 14.52B | |
+6.32% | 14.09B | |
+21.46% | 10.99B |
- Stock Market
- Equities
- MRUS Stock
- News Merus N.V.
- Merus N : Jumpstarts Collaborations in Israel, Italy, Spain for Cancer Patient Screening, Clinical Trial Awareness Raising